- From PLoS Tech, comes a post Article Level Metrics-Learning to Walk, Run & Do Algebra, featuring links to a recent presentation by bibliometics scholars intended to “provide some guidance and best practices for researchers and research administrators on how to use – and not use – bibliometrics to assess individuals”. The post includes a helpful list of 10 Don’ts.
- The decision by Blue Cross of California to not cover proton beam therapy for prostate cancer has generated some discussion about effectiveness, cost and coverage… Gary Schwitzer of Health News Review writes, Individual insurers doing what feds haven’t in refusing to pay for proton therapy?. Austin Fract has a few posts on this as well on his own blog, and one on JAMA Forum. What do you think?
- Carl Zimmer has an interesting article on gene therapy on Wired.
- A post on Xeconomy, Why Good Drugs Sometimes Fail: the Bexxar Story, quotes Anas Younes of MSKCC.
- The NY Times reviewed George Johnson’s new book, The Cancer Cronicles: Unlocking Medicine’s Deepest Mystery.
- Science magazine covered federal regulator’s efforts to deal with a rise in fecal transplants here.
Biomaterials is Now Available
Biomaterials
is an international peer-reviewed journal covering the science and clinical application of biomaterials. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents.
Biomaterials has an impact factor of 7.604 and the 5- year impact factor is 8.496. Users can access this journal through MSKsearch on the Library’s website or through the Library’s catalog, Tri-Cat.
Conquer Cancer Foundation: Available Funding Opportunities
The Conquer Cancer Foundation of the American Society of Clinical Oncology’s mission statement is “conquering cancer worldwide by funding breakthrough cancer research and sharing cutting-edge knowledge.” With this in mind, this organization offers several funding opportunities worth exploring.
Two forthcoming research grants both with application deadline of 11:59 pm EDT, September 26, 2013 include:
-
Career Development Award – three-year cancer grant totaling $200,000 providing funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program with a patient-oriented focus.
- Young Investigator Award – one-year research grant totaling $50,000 to an applicant who is a physician (MD, DO, or international equivalent) within the last two years of his/her final subspecialty training at an academic medical institution at the time of grant submission. This award provides funding to those focused on research in clinical oncology.
Vist the complete listing of funding opportunities to learn more about eligibility criteria and detailed instructions for submitting an application.